Skip to main content
Top
Published in: Breast Cancer Research 6/2010

Open Access 01-12-2010 | Research article

Using mammographic density to predict breast cancer risk: dense area or percentage dense area

Authors: Jennifer Stone, Jane Ding, Ruth ML Warren, Stephen W Duffy, John L Hopper

Published in: Breast Cancer Research | Issue 6/2010

Login to get access

Abstract

Introduction

Mammographic density (MD) is one of the strongest risk factors for breast cancer. It is not clear whether this association is best expressed in terms of absolute dense area or percentage dense area (PDA).

Methods

We measured MD, including nondense area (here a surrogate for weight), in the mediolateral oblique (MLO) mammogram using a computer-assisted thresholding technique for 634 cases and 1,880 age-matched controls from the Cambridge and Norwich Breast Screening programs. Conditional logistic regression was used to estimate the risk of breast cancer, and fits of the models were compared using likelihood ratio tests and the Bayesian information criteria (BIC). All P values were two-sided.

Results

Square-root dense area was the best single predictor (for example, χ12 = 53.2 versus 44.4 for PDA). Addition of PDA and/or square-root nondense area did not improve the fit (both P > 0.3). Addition of nondense area improved the fit of the model with PDA (χ12 = 11.6; P < 0.001). According to the BIC, the PDA and nondense area model did not provide a better fit than the dense area alone model. The fitted values of the two models were highly correlated (r = 0.97). When a measure of body size is included with PDA, the predicted risk is almost identical to that from fitting dense area alone.

Conclusions

As a single parameter, dense area provides more information than PDA on breast cancer risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.CrossRefPubMed McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.CrossRefPubMed
2.
go back to reference Yaffe M, Boyd N: Mammographic breast density and cancer risk: the radiological view. Gynecol Endocrinol. 2005, 21 (Suppl 1): 6-11. 10.1080/09513590400030053.CrossRefPubMed Yaffe M, Boyd N: Mammographic breast density and cancer risk: the radiological view. Gynecol Endocrinol. 2005, 21 (Suppl 1): 6-11. 10.1080/09513590400030053.CrossRefPubMed
3.
go back to reference Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed
4.
go back to reference Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.CrossRefPubMed Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.CrossRefPubMed
5.
go back to reference Hunter DJ, Willett WC: Diet, body size, and breast cancer. Epidemiol Rev. 1993, 15: 110-132.PubMed Hunter DJ, Willett WC: Diet, body size, and breast cancer. Epidemiol Rev. 1993, 15: 110-132.PubMed
6.
go back to reference Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995, 6: 137-141. 10.1097/00001648-199503000-00009.CrossRefPubMed Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995, 6: 137-141. 10.1097/00001648-199503000-00009.CrossRefPubMed
7.
go back to reference Ding J, Warren R, Warsi I, Day N, Thompson D, Brady M, Tromans C, Highnam R, Easton D: Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: case-control study. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1074-1081. 10.1158/1055-9965.EPI-07-2634.CrossRefPubMed Ding J, Warren R, Warsi I, Day N, Thompson D, Brady M, Tromans C, Highnam R, Easton D: Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: case-control study. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1074-1081. 10.1158/1055-9965.EPI-07-2634.CrossRefPubMed
8.
go back to reference McCormack VA, Highnam R, Perry N, dos Santos Silva I: Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1148-1154. 10.1158/1055-9965.EPI-07-0085.CrossRefPubMedPubMedCentral McCormack VA, Highnam R, Perry N, dos Santos Silva I: Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1148-1154. 10.1158/1055-9965.EPI-07-0085.CrossRefPubMedPubMedCentral
9.
go back to reference Highnam R, Pan X, Warren R, Jeffreys M, Davey Smith G, Brady M: Breast composition measurements using retrospective standard mammogram form (SMF). Phys Med Biol. 2006, 51: 2695-2713. 10.1088/0031-9155/51/11/001.CrossRefPubMed Highnam R, Pan X, Warren R, Jeffreys M, Davey Smith G, Brady M: Breast composition measurements using retrospective standard mammogram form (SMF). Phys Med Biol. 2006, 51: 2695-2713. 10.1088/0031-9155/51/11/001.CrossRefPubMed
10.
go back to reference Schwarz G: Estimating the dimension of a model. Ann Stat. 1978, 6: 461-464. 10.1214/aos/1176344136.CrossRef Schwarz G: Estimating the dimension of a model. Ann Stat. 1978, 6: 461-464. 10.1214/aos/1176344136.CrossRef
11.
go back to reference McQuarrie AD, Tsai CL: Regression and Time Series Model Selection. 1998, Singapore: World ScientificCrossRef McQuarrie AD, Tsai CL: Regression and Time Series Model Selection. 1998, Singapore: World ScientificCrossRef
12.
go back to reference Stone J, Ding J, Warren RM, Duffy SW: Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views. Breast Cancer Res Treat. 2010, 124: 551-554. 10.1007/s10549-010-0976-y.CrossRefPubMed Stone J, Ding J, Warren RM, Duffy SW: Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views. Breast Cancer Res Treat. 2010, 124: 551-554. 10.1007/s10549-010-0976-y.CrossRefPubMed
13.
go back to reference Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA: Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 43-49. 10.1158/1055-9965.EPI-06-0738.CrossRefPubMed Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA: Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 43-49. 10.1158/1055-9965.EPI-06-0738.CrossRefPubMed
14.
go back to reference Stone J, Warren RM, Pinney E, Warwick J, Cuzick J: Determinants of percentage and area measures of mammographic density. Am J Epidemiol. 2009, 170: 1571-1578. 10.1093/aje/kwp313.CrossRefPubMed Stone J, Warren RM, Pinney E, Warwick J, Cuzick J: Determinants of percentage and area measures of mammographic density. Am J Epidemiol. 2009, 170: 1571-1578. 10.1093/aje/kwp313.CrossRefPubMed
15.
go back to reference Vachon C, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.CrossRefPubMed Vachon C, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.CrossRefPubMed
16.
go back to reference Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed
17.
go back to reference Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT: Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007, 104: 47-56. 10.1007/s10549-006-9387-5.CrossRefPubMed Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT: Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007, 104: 47-56. 10.1007/s10549-006-9387-5.CrossRefPubMed
Metadata
Title
Using mammographic density to predict breast cancer risk: dense area or percentage dense area
Authors
Jennifer Stone
Jane Ding
Ruth ML Warren
Stephen W Duffy
John L Hopper
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2778

Other articles of this Issue 6/2010

Breast Cancer Research 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine